Does RABEPRAZOLE Cause Nephrogenic anaemia? 241 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 241 reports of Nephrogenic anaemia have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 2.1% of all adverse event reports for RABEPRAZOLE.
241
Reports of Nephrogenic anaemia with RABEPRAZOLE
2.1%
of all RABEPRAZOLE reports
54
Deaths
67
Hospitalizations
How Dangerous Is Nephrogenic anaemia From RABEPRAZOLE?
Of the 241 reports, 54 (22.4%) resulted in death, 67 (27.8%) required hospitalization.
Is Nephrogenic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 241 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Nephrogenic anaemia?
OMEPRAZOLE (2,873)
ESOMEPRAZOLE (2,869)
LANSOPRAZOLE (2,162)
PANTOPRAZOLE (2,118)
DEXLANSOPRAZOLE (825)
ESOMEPRAZOLE\NAPROXEN (107)
OMEPRAZOLE\SODIUM BICARBONATE (94)
SODIUM, DIBASIC\SODIUM, MONOBASIC (91)
DAPRODUSTAT (40)
EMTRICITABINE\TENOFOVIR DISOPROXIL (37)
Which RABEPRAZOLE Alternatives Have Lower Nephrogenic anaemia Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR